RCAR.US RenovaCare Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 22, 2025
0.0001 0.0001
Market cap
USD 8.74K
P/E
-
P/B
5.11x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.

Is RCAR.US undervalued?

Graham number

The Graham number of RenovaCare Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RenovaCare Inc fundamental analysis

No fundamental analysis for RenovaCare Inc yet.

RenovaCare Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RenovaCare Inc

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Sys…

Full company profile